Icelandic program seeks to eliminate HCV

March 7, 2018, Wiley
Electron micrographs of hepatitis C virus purified from cell culture. Scale bar is 50 nanometers. Credit: Center for the Study of Hepatitis C, The Rockefeller University.

A new Journal of Internal Medicine study describes an innovative program to eliminate hepatitis C virus (HCV) as a public health threat in Iceland.

In the TraP Hep C program, which started in January 2016, an emphasis is placed on finding early cases and treating patients at high risk for transmitting HCV: people who inject drugs. All patients with national health insurance are offered treatment regardless of fibrosis stage and .

The program includes a multidisciplinary public health model of care and cooperation between government, health services, the penitentiary system, and community organizations. The results of the Icelandic project will provide important data and inform others globally trying to achieve the World Health Organization's goal of HCV elimination by 2030.

"So far this project has been extremely well received by patients, and we are aiming to complete the active treatment phase, encompassing all known cases in the country, by the end of 2018," said senior author Dr. Magnus Gottfredsson, of the University of Iceland.

Explore further: More than one third of U.S. HIV patients fail to receive vaccination for hepatitis B

More information: S. Olafsson et al, Treatment as Prevention for Hepatitis C (TraP Hep C) - a nationwide elimination programme in Iceland using direct-acting antiviral agents, Journal of Internal Medicine (2018). DOI: 10.1111/joim.12740

Related Stories

More than one third of U.S. HIV patients fail to receive vaccination for hepatitis B

December 25, 2017
Despite their high risk for infection, more than one third of U.S. HIV patients fail to get vaccinated for hepatitis B. The findings are published in Annals of Internal Medicine.

Only nine countries on track to eliminate hepatitis C

November 1, 2017
New data on hepatitis C released by the Polaris Observatory, and presented today at the World Hepatitis Summit (WHS) in Sao Paulo, Brazil shows that nine countries—Australia, Brazil, Egypt, Georgia, Germany, Iceland, Japan, ...

Countries risk 'running out' of hepatitis C patients to treat, says World Hepatitis Alliance

November 1, 2017
The latest data on the global hepatitis C epidemic, released today at the World Hepatitis Summit in Sao Paulo, Brazil (1-3 November) reveal that most countries (especially high-income countries) are running out of patients ...

World Hepatitis Day sets the stage for the elimination of viral hepatitis

July 28, 2017
Today, World Hepatitis Day, marks the first time that the global health community has come together to officially begin moving towards the elimination of viral hepatitis by 2030.

People who use drugs require prioritization, not exclusion, in HCV elimination

September 6, 2017
An international conference bringing together hepatitis C experts from around the world is today calling for strategies to prioritise people who use drugs, saying hepatitis C elimination is impossible without them.

Australia currently on track to eliminate hepatitis C by 2030, but challenges remain for hepatitis B

November 1, 2017
New data released at this year's World Hepatitis Summit in Sao Paulo, Brazil (1-3 November) shows that Australia is currently on track to eliminate hepatitis C thanks to its huge efforts to enable population-wide access to ...

Recommended for you

Global burden of low back pain—a consequence of negligence and misinformation

March 21, 2018
A series of groundbreaking papers from Australian and international researchers in The Lancet, published today (22/3) warns that low back pain is a major health burden globally - across developed and developing nations - ...

Microscopic 'shuttles' transport enzyme from cells to trigger onset of kidney disease

March 21, 2018
A new study involving the University of Sheffield has identified a key culprit in the onset of kidney disease in a major marker for kidney disease development.

Metabolite therapy proves effective in treating C. difficile in mice

March 20, 2018
A team of UCLA researchers found that a metabolite therapy was effective in mice for treating a serious infection of the colon known as Clostridium difficile infection, or C. difficile.

Study of COPD patients has created a 'looking glass' into genome of pathogen

March 19, 2018
Decades of work on chronic obstructive pulmonary disease (COPD) at the University at Buffalo and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the pathogen that does ...

Sick air travelers mostly likely to infect next row: study

March 19, 2018
People who fly on airplanes while contagious can indeed get other people sick, but the risk is mainly to those seated next to them or in the adjacent row, US researchers said Monday.

Newly described human antibody prevents malaria in mice

March 19, 2018
Scientists have discovered a human antibody that protected mice from infection with the deadliest malaria parasite, Plasmodium falciparum. The research findings provide the basis for future testing in humans to determine ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.